These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29486970)

  • 1. Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1.
    Varnes JG; Xiong H; Forst JM; Holmquist CR; Ernst GE; Frietze W; Dembofsky B; Andisik DW; Palmer WE; Hinkley L; Steelman GB; Wilkins DE; Tian G; Jonak G; Potts WM; Wang X; Brugel TA; Alhambra C; Wood MW; Veale CA; Albert JS
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1043-1049. PubMed ID: 29486970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based lead.
    Jones CK; Sheffler DJ; Williams R; Jadhav SB; Felts AS; Morrison RD; Niswender CM; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1067-70. PubMed ID: 24461352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
    Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides.
    Lindsley CW; Zhao Z; Leister WH; O'Brien J; Lemaire W; Williams DL; Chen TB; Chang RS; Burno M; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Tsou NN; Duggan ME; Conn PJ; Hartman GD
    ChemMedChem; 2006 Aug; 1(8):807-11. PubMed ID: 16902933
    [No Abstract]   [Full Text] [Related]  

  • 6. Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.
    Cioffi CL; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Dethe D; Maeng JH; Carulli E; Loong DT; Fang X; Hu M; Gupta P; Chung M; Bai M; Moore N; Luche M; Khmelnitsky Y; Love PL; Watson MA; Mhyre AJ; Liu S
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1257-61. PubMed ID: 23380375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
    Cioffi CL; Liu S; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Loong DT; Maeng JH; Carulli E; Fang X; Karunakaran K; Matta L; Choo SH; Panduga S; Buckle RN; Davis RN; Sakwa SA; Gupta P; Sargent BJ; Moore NA; Luche MM; Carr GJ; Khmelnitsky YL; Ismail J; Chung M; Bai M; Leong WY; Sachdev N; Swaminathan S; Mhyre AJ
    J Med Chem; 2016 Sep; 59(18):8473-94. PubMed ID: 27559615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat.
    Cervo L; Di Clemente A; Orrù A; Moro F; Cassina C; Pich EM; Corsi M; Gozzi A; Bifone A
    Addict Biol; 2013 Sep; 18(5):800-11. PubMed ID: 23490434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
    Komatsu H; Furuya Y; Sawada K; Asada T
    Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of potent glycine transporter type-2 inhibitors: design and synthesis of phenoxymethylbenzamide derivatives.
    Takahashi E; Arai T; Akahira M; Nakajima M; Nishimura K; Omori Y; Kumagai H; Suzuki T; Hayashi R
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4603-4606. PubMed ID: 25176190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
    Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
    Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.
    Nikiforuk A; Kos T; Rafa D; Behl B; Bespalov A; Popik P
    Neuropharmacology; 2011; 61(1-2):262-7. PubMed ID: 21530555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 4-(2-pyrimidinylamino)benzamide derivatives as potent hedgehog signaling pathway inhibitors.
    Xin M; Zhang L; Tu C; Tang F; Wen J
    Bioorg Med Chem; 2018 Oct; 26(18):5029-5036. PubMed ID: 30249494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour.
    Singer P; Feldon J; Yee BK
    Eur Neuropsychopharmacol; 2009 Aug; 19(8):571-80. PubMed ID: 19282154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2.
    Brugel TA; Smith RW; Balestra M; Becker C; Daniels T; Koether GM; Throner SR; Panko LM; Brown DG; Liu R; Gordon J; Peters MF
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5405-10. PubMed ID: 20719509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.
    Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M
    Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
    Varnes JG; Forst JM; Hoerter TN; Holmquist CR; Wilkins DE; Tian G; Jonak G; Wang X; Potts WM; Wood MW; Alhambra C; Brugel TA; Albert JS
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4878-81. PubMed ID: 20637614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
    Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
    Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
    Kalinichev M; Starr KR; Teague S; Bradford AM; Porter RA; Herdon HJ
    Brain Res; 2010 May; 1331():105-13. PubMed ID: 20303337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.